Neolepra F 3/25mg Tablet

Neolepra F 3/25mg Tablet is a combination medication containing two active ingredients: Olanzapine & Fluoxetine. Olanzapine belongs to the class of atypical antipsychotic medications, while Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant. This combination is prescribed for the treatment of depressive episodes associated with bipolar disorder and treatment-resistant depression.

Uses:

Neolepra F 3/25mg Tablet is used for the management of depressive episodes associated with bipolar disorder and treatment-resistant depression. It works by modulating the levels of neurotransmitters such as serotonin and dopamine in the brain, thereby alleviating symptoms of depression and stabilizing mood. This combination medication is prescribed when monotherapy with either Olanzapine or Fluoxetine has not provided sufficient symptom relief.

Dosage:

The dosage of Neolepra F 3/25mg Tablet is determined by the healthcare provider based on factors such as the patient’s medical history, severity of symptoms, and response to treatment. It is usually taken orally once daily, preferably in the evening, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the prescribed dosage and administration instructions provided by their healthcare provider.

Side Effects:

Common side effects associated with Neolepra F 3/25mg Tablet may include drowsiness, dizziness, dry mouth, constipation, weight gain, and changes in appetite. These side effects are usually mild to moderate and may improve over time. In some cases, more serious side effects such as extrapyramidal symptoms, metabolic changes, or serotonin syndrome may occur. Patients should report any adverse reactions to their healthcare provider promptly.

Precautions:

Before using Neolepra F 3/25mg Tablet, patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. It is essential to use caution in patients with a history of cardiovascular disease, seizures, or diabetes. This medication may interact with other drugs, so it’s crucial to review the patient’s medication regimen to avoid potential interactions.

When Not to Use:

Neolepra F 3/25mg Tablet is contraindicated in patients with a known hypersensitivity to Olanzapine, Fluoxetine, or any other components of the medication. It should not be used concomitantly with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy. Additionally, this combination medication is not recommended for use in pediatric patients without the guidance of a healthcare provider.